OCUL
Ocular Therapeutix Inc
Price:  
9.10 
USD
Volume:  
2,073,422.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCUL EV/EBITDA

-238.2%
Upside

As of 2025-07-02, the EV/EBITDA ratio of Ocular Therapeutix Inc (OCUL) is -5.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OCUL's latest enterprise value is 1,169.15 mil USD. OCUL's TTM EBITDA according to its financial statements is -200.30 mil USD. Dividing these 2 quantities gives us the above OCUL EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.2x - 10.2x 8.1x
Forward P/E multiples 11.1x - 17.6x 14.7x
Fair Price (12.20) - (11.04) (12.57)
Upside -234.0% - -221.3% -238.2%
9.10 USD
Stock Price
(12.57) USD
Fair Price

OCUL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-26 -5.98
2025-06-25 -5.91
2025-06-24 -5.83
2025-06-23 -5.26
2025-06-20 -5.07
2025-06-18 -5.22
2025-06-17 -5.20
2025-06-16 -5.56
2025-06-13 -5.54
2025-06-12 -5.72
2025-06-11 -5.61
2025-06-10 -5.69
2025-06-09 -5.68
2025-06-06 -5.77
2025-06-05 -5.33
2025-06-04 -5.26
2025-06-03 -5.22
2025-06-02 -5.05
2025-05-30 -4.97
2025-05-29 -5.07
2025-05-28 -4.87
2025-05-27 -4.12
2025-05-23 -4.41
2025-05-22 -4.34
2025-05-21 -4.41
2025-05-20 -4.64
2025-05-19 -4.57
2025-05-16 -4.34
2025-05-15 -4.30
2025-05-14 -4.11
2025-05-13 -4.17
2025-05-12 -4.48
2025-05-09 -4.21
2025-05-08 -4.52
2025-05-07 -4.21
2025-05-06 -4.31
2025-05-05 -4.75
2025-05-02 -5.60
2025-05-01 -5.38
2025-04-30 -5.20
2025-04-29 -5.13
2025-04-28 -5.07
2025-04-25 -4.73
2025-04-24 -4.88
2025-04-23 -4.84
2025-04-22 -4.89
2025-04-21 -4.65
2025-04-17 -4.41
2025-04-16 -4.30
2025-04-15 -4.59